Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: lack of effect of L-carnitine supplementation

References

• Anonymous. Longterm survival on dialysis. Lancet 1983; ii: 889–90
   Google Scholar
• Lazarus J M, Lowrie E G, Hampers C L, Merril J P. Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 1975; 7(suppl 2)S-167–75
   Web of Science ®Google Scholar
• Bagdade J D. Atherosclerosis in patients undergoing maintenance hemodialysis. Kidney Int 1975; 7(suppl 3)S-370–2
   Google Scholar
• Bagdade J D, Albers J J. Plasma high-density lipoprotein concentration in chronic hemodialysis and renal transplant patients. New Engl J Med 1977; 296: 1436–9
   PubMed Web of Science ®Google Scholar
• Bolzano K, Krempler F, Sandhofer F. Hepatic and extrahepatic triglyceride lipase activity in uraemic patients on chronic hemodialysis. Eur J Clin Invest 1978; 8: 289–93
   PubMed Web of Science ®Google Scholar
• Brunzell J D, Albers J J, Haas L B, Goldberg A P, Agadoa L, Sherrard D J. Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 1977; 26: 903–10
   PubMed Web of Science ®Google Scholar
• Ibels L S, Simons L A, King J O, Williams P F, Neale F C, Stewart J H. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation. Q J Med 1975; 44: 601–14
   PubMedGoogle Scholar
• Nicholls A J, Cumming A M, Catto G RD, Edward N, Engeset J. Lipid relationshi'ps in dialysis and renal transplant patients. O J Med 1981; 198: 149–60
   Google Scholar
• Rapoport J, Aviram M, Chaimovitz C, Brook J G. Defective high-density lipoprotein composition in patients on chronic hemodialysis. New Engl J Med 1978; 299: 1326–9
   PubMed Web of Science ®Google Scholar
• Tsaltas T T, Friedman E A. Plasma lipid studies of uremic patients during hemodialysis. Am J Clin Nutr 1968; 21: 430–5
   PubMed Web of Science ®Google Scholar
• Appelbaum-Bowden D, Goldberg A P, Hazzard W R, et al. Postheparin plasma triglyceride lipases in chronic haemodialysis: evidence for a role of hepatic lipase in lipoprotein metabolism. Metabolism 1979; 28: 917–24
   PubMedGoogle Scholar
• Felts J M, Zacherle B, Childress G. Lipoprotein spectrum analysis of uremic patients maintained on chronic hemodialysis. Clin Chim Acta 1979; 93: 127–34
   PubMed Web of Science ®Google Scholar
• Mordasini R, Frey F, Flury W, Klose G, Greten H. Selective deficiency of hepatic triglyceride lipase in uremic patients. New Engl J Med 1977; 297: 1362–6
   PubMed Web of Science ®Google Scholar
• Goldberg A P, Applebaum-Bowden D M, Bier-man E L, et al. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. New Engl J Med 1979; 301: 1073–6
   PubMed Web of Science ®Google Scholar
• Böhmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent hemodialysis for renal failure. Lancet 1978; i: 126–8
   Google Scholar
• Bertoli M, Battistella P A, Vergani L, et al. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Am J Clin Nutr 1981; 34: 1496–9
   PubMed Web of Science ®Google Scholar
• Bougneres P F, Lacour B, DiGiulio S, Assan R. Hypolipaemic effect of carnitine in uraemic patients. Lancet 1979; i: 1401–2
   Google Scholar
• Guarnieri G F, Ranieri F, Toigo G, et al. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am J Clin Nutr 1980; 33: 1489–92
   PubMed Web of Science ®Google Scholar
• Lacour B, Chanrad J, Haquet M. Carnitine improves lipid anomalies in haemodialysis patients. Lancet 1980; ii: 763–5
   Google Scholar
• Casciani C U, Caruso U, Cravotto E, Corsi M, Maccari F. Beneficial effects of L-carnitine in post-dialysis syndrome. Curr Ther Res 1982; 32: 116–27
   Web of Science ®Google Scholar
• Aubia J, Masramon J, Lloveras J, Llorach M, Andolz P. Carnitine in haemodialysis patients. Lancet 1980; ii: 1028–9
   Google Scholar
• Chan M K, Persaud J W, Varghese Z, Baillod R A, Moorhead J F. Response patterns to D, L-carnitine in patients on maintenance haemodialysis. Nephron 1982; 30: 240–3
   PubMed Web of Science ®Google Scholar
• Fagher B, Thysell H, Nilsson-Ehle P, et al. The effect of D, L-carnitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic function in hemodialysis patients. Acta Med Scand 1982; 212: 115–20
   PubMedGoogle Scholar
• Wechsler A, Aviram M, Levin M, Better O S, Brook J G. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis. Nephron 1984; 38: 120–124
   PubMed Web of Science ®Google Scholar
• Carlson L A, Rossner S. A methodological study of an intravenous fat tolerance test with Intralipid emulsion. Scand J Clin Lab Invest 1972; 29: 243–9
   PubMed Web of Science ®Google Scholar
• Nilsson-Ehle P, Ekman R. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 1977; 3: 194–209
   Google Scholar
• Danielsson B, Ekman R, Fex G, et al. Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 1978; 38: 113–19
   PubMed Web of Science ®Google Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–506
   PubMed Web of Science ®Google Scholar
• Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol 1983; 104: 50–6
   PubMedGoogle Scholar
• Chan M K, Varghese Z, Persaud J W, Baillod R A, Moorhead J F. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal. Clin Nephrol 1982; 17: 183–90
   PubMed Web of Science ®Google Scholar
• Russel G I, Davies T G, Walls J. Evaluation of the intravenous fat tolerance test in chronic renal disease. Clin Nephrol 1980; 13: 282–6
   PubMed Web of Science ®Google Scholar
• Kaptein E M, Feinstein E I, Massry S G. Thyroid hormone metabolism in renal diseases. Contr Nephrol 1982; 33: 122–35
   PubMed Web of Science ®Google Scholar
• Sauar J, Holme R, Blomhoff J P. Triglyceride lipase activity in postheparin plasma and plasma lipoproteins in liver disease. Clin Chim Acta 1978; 87: 327–40
   PubMed Web of Science ®Google Scholar
• Murase T, Cattran D C, Rubinstein B, Steiner G. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 1975; 24: 1279–86
   PubMed Web of Science ®Google Scholar
• Vacha G M, Giorcelli G, Siliprandi N, Corsi M. Favourable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 1983; 38: 532–40
   PubMed Web of Science ®Google Scholar
• Trovato G M, Ginardi V, Di Marco V, DellˆAira A E, Corsi M. Long-term L-carnitine treatment of chronic anaemia of patients with end-stage renal failure. Curr Ther Res 1982; 31: 1042–9
   Web of Science ®Google Scholar